Current Ratio of Elicio Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Elicio Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Elicio Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 218%, a 3.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Elicio Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 218% +8% +3.7% 30 Sep 2025
Q2 2025 227% +62% +38% 30 Jun 2025
Q1 2025 200% -21% -9.3% 31 Mar 2025
Q4 2024 212% -122% -37% 31 Dec 2024
Q3 2024 210% -139% -40% 30 Sep 2024
Q2 2024 164% -380% -70% 30 Jun 2024
Q1 2024 220% -479% -69% 31 Mar 2024
Q4 2023 334% -297% -47% 31 Dec 2023
Q3 2023 348% -422% -55% 30 Sep 2023
Q2 2023 544% -169% -24% 30 Jun 2023
Q1 2023 700% +48% +7.4% 31 Mar 2023
Q4 2022 631% -42% -6.2% 31 Dec 2022
Q3 2022 771% +525% +214% 30 Sep 2022
Q2 2022 713% 30 Jun 2022
Q1 2022 651% 31 Mar 2022
Q4 2021 673% 31 Dec 2021
Q3 2021 246% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.